Stable Factor IX Activity Following AAV-mediated Gene Transfer in Patients with Severe Hemophilia B.

被引：0
|
作者：
Nathwani, Amit [1 ,2 ]
机构：
[1] UCL, London, England
[2] Royal Free Hosp, London NW3 2QG, England
来源：
HUMAN GENE THERAPY | 2012年 / 23卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A16 / A16
页数：1
相关论文
共 50 条
  • [1] Stable Factor IX Activity Following AAV-Mediated Gene Transfer in Patients with Severe Hemophilia B
    Davidoff, Andrew
    Tuddenham, Edward G. D.
    Rangarajan, Savita
    Rosales, Cecilia
    McIntosh, Jenny
    Chowdary, Pratima
    Riddell, Anne
    Glader, Bertil
    Rustagi, Pradip
    Ng, Catherine
    Kay, Mark
    Zhou, Junfang
    Spence, Yunyu
    Morton, Christopher
    Allay, James
    Sleep, Susan
    Basner-Tschakarjan, Etiena
    Mingozzi, Federico
    High, Katherine A.
    Gray, John T.
    Reiss, Ulrike M.
    Nienhuis, Arthur W.
    Nathwani, Amit C.
    BLOOD, 2012, 120 (21)
  • [2] AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
    Manno, CS
    Chew, AJ
    Hutchison, S
    Larson, PJ
    Herzog, RW
    Arruda, VP
    Tai, SJ
    Ragni, MV
    Thompson, A
    Ozelo, M
    Couto, LB
    Leonard, DGB
    Johnson, FA
    McClelland, A
    Scallan, C
    Skarsgard, E
    Flake, AW
    Kay, MA
    High, KA
    Glader, B
    BLOOD, 2003, 101 (08) : 2963 - 2972
  • [3] AAV-mediated gene transfer in dogs with hemophilia B.
    Herzog, RW
    Yang, EY
    Couto, LB
    Hagstrom, JN
    Elwell, D
    Chu, K
    Kung, SH
    Tai, SJ
    McQuiston, SA
    Colosi, P
    Podsakoff, GM
    Read, MS
    Bellinger, DA
    Brinkhous, KM
    Nichols, T
    Kurtzman, GJ
    High, KA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (03) : 215A - 215A
  • [4] The use of factor IX variants improves AAV-mediated gene therapy for hemophilia B.
    Schuettrumpf, J
    Herzog, RW
    Kaufhold, A
    Stafford, DW
    High, KA
    Arruda, VR
    BLOOD, 2002, 100 (11) : 17A - 17A
  • [5] AAV-mediated gene therapy for hemophilia B.
    High, K
    Arruda, V
    Couto, L
    McClelland, A
    Kay, M
    Glader, B
    Herzog, R
    FASEB JOURNAL, 2000, 14 (08): : A1310 - A1310
  • [6] Gene therapy for hemophilia B: AAV-mediated transfer of the gene for coagulation factor IX to human muscle
    Larson, PJ
    High, KA
    HEMOPHILIA CARE IN THE NEW MILLENNIUM, 2001, 489 : 45 - 57
  • [7] Immune responses to AAV and to factor IX in a phase I study of AAV-mediated, liver-directed gene transfer for hemophilia B.
    High, KA
    Manno, CS
    Sabatino, DE
    Hutchison, S
    Dake, M
    Razavi, M
    Kaye, R
    Arruda, VR
    Herzog, RW
    Rustagi, PK
    Rasko, JEJ
    Hoots, K
    Blatt, P
    Sommer, J
    Leonard, DDB
    Addya, K
    Ragni, MV
    Ozelo, M
    Konkle, BA
    Lessard, R
    Axsom, KM
    Chew, AJ
    Glader, B
    Pierce, G
    Couto, LB
    Kay, MA
    BLOOD, 2003, 102 (11) : 154A - 155A
  • [8] Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B
    Jiang, Haiyan
    Pierce, Glenn F.
    Ozelo, Margareth C.
    de Paula, Erich V.
    Vargas, Joseph A.
    Smith, Peter
    Summer, Juerg
    Luk, Alvin
    Manno, Catherine S.
    High, Katherine A.
    Arruda, Valder R.
    MOLECULAR THERAPY, 2006, 14 (03) : 452 - 455
  • [9] AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B (vol 101, pg 2963, 2003)
    Manno
    BLOOD, 2003, 102 (03) : 788 - 788
  • [10] An animal model of transient transaminitis and diminished factor IX expression following AAV-mediated, liver-directed gene transfer for hemophilia B.
    Sabatino, DE
    Brooks, DC
    Schlachterman, A
    Liu, YL
    Chen, H
    Colosi, P
    Couto, LB
    High, KA
    BLOOD, 2003, 102 (11) : 493A - 494A
12345